Literature DB >> 32509514

Treatment outcomes of laser therapy in oral submucous fibrosis-a systematic review.

Dr Shailesh M Gondivkar1, Dr Amol R Gadbail2, Dr Sachin C Sarode3, Dr Rima S Gondivkar4, Shankargouda Patil5, Dr Rahul N Gaikwad6, Dr Monal Yuwanati7.   

Abstract

BACKGROUND: The mainstay of oral submucous fibrosis (OSF) management is to increase the mouth opening; thereby improving oral functionalities. In modernized dentistry, laser therapy (LT) could play a major role for trismus relief in OSF patients. The present review was performed to systematically analyze the published literature on LT for OSF management.
METHODS: PubMed, Scopus, Web of Science and CINAHL databases were searched until June 2019 using suitable key words and the information was extracted according to the PRISMA guidelines. All full text papers that assessed efficacy of LT for OSF management without limitations on age, gender, ethnicity, or socioeconomic status of the participants were considered eligible. Participants were allocated to the LT alone or in adjunct to oral physiotherapy and medicinal treatment. Outcome parameters included the reduction in trismus. Review articles, case reports, editorial, conference abstracts and in vitro studies were excluded. No restriction was applied on date and language of the publications.
RESULTS: Out of 97 published papers, 7 studies met the inclusion criteria and were included for the analysis. All the studies were clinical and mainly included stage II and III OSF patients. Although different laser types and other parameters were used, all the studies reported improvement in mouth opening in the range of 6.84 mm and 23.7 mm. Additionally, two studies noticed reduced burning sensation and increased tongue protrusion and cheek flexibility.
Conclusion: The LT can provide a promising and better means for relieving trismus and probably OSF-related other symptoms in moderate stages of the disease.
© 2020 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Laser therapy; Oral submucous fibrosis; Systematic review; Trismus

Year:  2020        PMID: 32509514      PMCID: PMC7264056          DOI: 10.1016/j.jobcr.2020.05.004

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  29 in total

1.  Morphological changes of bovine mandibular bone irradiated by Er,Cr:YSGG laser: an in vitro study.

Authors:  Xiaogu Wang; Nelson Tatsunari Ishizaki; Nobuyuki Suzuki; Yuichi Kimura; Koukichi Matsumoto
Journal:  J Clin Laser Med Surg       Date:  2002-10

2.  Role of KTP-532 laser in management of oral submucous fibrosis.

Authors:  D R Nayak; S G Mahesh; D Aggarwal; P Pavithran; K Pujary; S Pillai
Journal:  J Laryngol Otol       Date:  2008-10-10       Impact factor: 1.469

3.  Surgical management of trismus due to Oral Submucous Fibrosis - Lysis of fibrotic bands with the KTP-532 Laser.

Authors:  Mohan Kameshwaran; Dilip Raghavan; R S Anand Kumar; Sathiya Murali
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-07

4.  Effectiveness of root planing with diode laser curettage for the treatment of periodontitis.

Authors:  Joseph Zingale; Lisa Harpenau; David Chambers; William Lundergan
Journal:  J Calif Dent Assoc       Date:  2012-10

5.  The Efficacy of ErCr:YSGG Laser Fibrotomy in Management of Moderate Oral Submucous Fibrosis: A Preliminary Study.

Authors:  Zainab Chaudhry; Shalini R Gupta; Sukhvinder Singh Oberoi
Journal:  J Maxillofac Oral Surg       Date:  2013-04-18

6.  Coming to America: betel nut and oral submucous fibrosis.

Authors:  Shahid R Aziz
Journal:  J Am Dent Assoc       Date:  2010-04       Impact factor: 3.634

Review 7.  Review of drug treatment of oral submucous fibrosis.

Authors:  Revant H Chole; Shailesh M Gondivkar; Amol R Gadbail; Swati Balsaraf; Sudesh Chaudhary; Snehal V Dhore; Sumeet Ghonmode; Satish Balwani; Mugdha Mankar; Manish Tiwari; Rima V Parikh
Journal:  Oral Oncol       Date:  2011-12-27       Impact factor: 5.337

8.  Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.

Authors:  Amol Ramchandra Gadbail; Minal Chaudhary; Madhuri Gawande; Alka Hande; Sachin Sarode; Satyajit Ashok Tekade; Sheetal Korde; Prajakta Zade; Rahul Bhowate; Rajiv Borle; Swati Patil
Journal:  J Oral Pathol Med       Date:  2017-02-28       Impact factor: 4.253

9.  Quality of Life-related "Patient-reported Outcome Measures" in Oral Submucous Fibrosis Patients.

Authors:  Shailesh M Gondivkar; Rahul R Bhowate; Amol R Gadbail; Sachin C Sarode; Rima S Gondivkar; Monal Yuwanati; Shankargouda Patil
Journal:  J Contemp Dent Pract       Date:  2018-03-01

10.  Impact of socioeconomic inequalities on quality of life in oral submucous fibrosis patients.

Authors:  Shailesh M Gondivkar; Rahul R Bhowate; Amol R Gadbail; Rima S Gondivkar; Sachin C Sarode
Journal:  Future Oncol       Date:  2019-01-23       Impact factor: 3.404

View more
  3 in total

Review 1.  Efficacy of Topical Intervention for Recurrent Aphthous Stomatitis: A Network Meta-Analysis.

Authors:  Hao Liu; Lei Tan; Gege Fu; Ling Chen; Hua Tan
Journal:  Medicina (Kaunas)       Date:  2022-06-07       Impact factor: 2.948

2.  Significantly higher serum tumor marker levels in patients with oral submucous fibrosis.

Authors:  Yu-Hsueh Wu; Ping-Yi Lin; Ju-Hsuan Yang; Ying-Shiung Kuo; Yang-Che Wu; Chun-Pin Chiang
Journal:  J Dent Sci       Date:  2021-03-11       Impact factor: 2.080

Review 3.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.